Tag: biotechnology
-
Engineered Virus Delivers Brain-Targeted Gene Therapy
Neuroscience researchers designed a process for delivering gene therapies through the blood stream, but targeting only brain cells of lab animals.
-
Messenger RNA Developer ETF Launches
A new exchange traded fund or ETF is underway for individuals to invest in companies developing vaccines or therapies with messenger RNA.
-
Oxford, GSK Partner on New Tech for Neuro Diseases
GlaxoSmithKline is funding a joint research center at University of Oxford to advance precision medical technologies, beginning with neurological disorders.
-
$180M Venture Fund Backing Age-Related Disease Start-Ups
A new venture capital fund aims to finance research entrepreneurs addressing root causes of age-related diseases with therapies and early diagnostics.
-
Covid-19 Antibody Cocktail Trial Request Filed
A discoverer of synthetic antibodies is asking Food and Drug Administration for clearance to begin a clinical trial of a Covid-19 antibody cocktail therapy.
-
Plant-Based Protein Biotech Raises $3M in Seed Funds
A biotechnology start-up producing proteins with more sustainable and less costly plant-based processes is raising $3 million in its seed funding round.
-
Samsung, Biotech Partner on mRNA Vaccine Production
A developer of synthetic RNA products is partnering with Samsung Biologics to manufacture Covid-19 vaccines made with messenger RNA.
-
Regeneron Gains Cancer, Infectious Disease Immunotherapies
A biotechnology company is licensing five of its vaccines for cancer and infectious diseases to Regeneron Pharmaceuticals in a deal valued at nearly $1 billion.
-
Cell Therapy Start-Up Raises $6M in Seed Funds
A new company providing clinical development and commercialization for emerging cell therapies began operations and raised $6 million in seed funding.
-
Novo Nordisk Buys RNA Biotech in $3.3B Deal
Global drug maker Novo Nordisk is acquiring biotechnology company Dicerna Pharmaceuticals Inc. in an all-cash deal valued at $3.3 billion.